| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 67,986 | 70,378 | 69,385 | 65,110 | | Cost of Revenue | (70,716) | 56,545 | 39,859 | (4,643) | | | Gross Profit | 138,702 | 13,833 | 29,526 | 69,753 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 128,053 | 1,255 | 18,437 | 28,295 | | Non Recurring |
-
|
-
|
-
| 30,821 | | Others | 4,977 | 5,124 | 5,140 | 5,367 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,672 | 7,454 | 5,949 | 5,270 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 5,672 | 7,454 | 5,949 | 5,067 | | Interest Expense | 2,927 | 2,187 | 3,370 | 2,929 | | Income Before Tax | 2,745 | 5,267 | 2,579 | 2,138 | | Income Tax Expense | 1,091 | 2,091 | 1,021 | 828 | | Minority Interest | (524) |
-
|
-
| (203) | | | | Net Income From Continuing Ops | 1,130 | 3,176 | 1,558 | 1,310 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,130 | 3,176 | 1,558 | 1,310 | | Preferred Stock And Other Adjustments | 301 | (164) | (137) |
-
| | | Net Income Applicable To Common Shares | $1,431 | $3,012 | $1,421 | $1,310 |
|
0.08% Nasdaq 
Income Statement
